390 related articles for article (PubMed ID: 15780102)
1. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000).
Van Dijk PC; Jager KJ; Stengel B; Grönhagen-Riska C; Feest TG; Briggs JD
Kidney Int; 2005 Apr; 67(4):1489-99. PubMed ID: 15780102
[TBL] [Abstract][Full Text] [Related]
2. Incidence of renal replacement therapy for diabetic nephropathy in the Netherlands: Dutch diabetes estimates (DUDE)-3.
van Dijk PR; Kramer A; Logtenberg SJ; Hoitsma AJ; Kleefstra N; Jager KJ; Bilo HJ
BMJ Open; 2015 Jan; 5(1):e005624. PubMed ID: 25636789
[TBL] [Abstract][Full Text] [Related]
3. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006.
Kramer A; Stel V; Zoccali C; Heaf J; Ansell D; Grönhagen-Riska C; Leivestad T; Simpson K; Pálsson R; Postorino M; Jager K;
Nephrol Dial Transplant; 2009 Dec; 24(12):3557-66. PubMed ID: 19820003
[TBL] [Abstract][Full Text] [Related]
4. Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries.
van Dijk PC; Jager KJ; de Charro F; Collart F; Cornet R; Dekker FW; Grönhagen-Riska C; Kramar R; Leivestad T; Simpson K; Briggs JD;
Nephrol Dial Transplant; 2001 Jun; 16(6):1120-9. PubMed ID: 11390709
[TBL] [Abstract][Full Text] [Related]
5. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005).
Villar E; Chang SH; McDonald SP
Diabetes Care; 2007 Dec; 30(12):3070-6. PubMed ID: 17848610
[TBL] [Abstract][Full Text] [Related]
6. The 2006 ERA-EDTA Registry annual report: a précis.
Stel VS; Kramer A; Zoccali C; Jager KJ
J Nephrol; 2009; 22(1):1-12. PubMed ID: 19229813
[TBL] [Abstract][Full Text] [Related]
7. Differences in renal registries between the Balkans and Western Europe.
Stojceva-Taneva O; Selim GJ; Zafirovska K; Polenakovic M
Prilozi; 2006 Dec; 27(2):37-47. PubMed ID: 17211290
[TBL] [Abstract][Full Text] [Related]
8. Renal replacement therapy in patients with diabetic nephropathy, 1980-1985. Report from the European Dialysis and Transplant Association Registry.
Brunner FP; Brynger H; Challah S; Fassbinder W; Geerlings W; Selwood NH; Tufveson G; Wing AJ
Nephrol Dial Transplant; 1988; 3(5):585-95. PubMed ID: 3146713
[TBL] [Abstract][Full Text] [Related]
9. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002.
; Stewart JH; McCredie MR; Williams SM
Nephrol Dial Transplant; 2006 Aug; 21(8):2178-83. PubMed ID: 16595584
[TBL] [Abstract][Full Text] [Related]
10. Diabetic nephropathy and end-stage renal failure: the Norwegian story.
Bergrem H; Leivestad T
Adv Ren Replace Ther; 2001 Jan; 8(1):4-12. PubMed ID: 11172323
[TBL] [Abstract][Full Text] [Related]
11. The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry.
Pippias M; Jager KJ; Kramer A; Leivestad T; Sánchez MB; Caskey FJ; Collart F; Couchoud C; Dekker FW; Finne P; Fouque D; Heaf JG; Hemmelder MH; Kramar R; De Meester J; Noordzij M; Palsson R; Pascual J; Zurriaga O; Wanner C; Stel VS
Nephrol Dial Transplant; 2016 May; 31(5):831-41. PubMed ID: 26361801
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.
Hruskova Z; Pippias M; Stel VS; Abad-Díez JM; Benítez Sánchez M; Caskey FJ; Collart F; De Meester J; Finne P; Heaf JG; Magaz A; Palsson R; Reisæter AV; Salama AD; Segelmark M; Traynor JP; Massy ZA; Jager KJ; Tesar V
Am J Kidney Dis; 2019 Feb; 73(2):184-193. PubMed ID: 30122544
[TBL] [Abstract][Full Text] [Related]
13. Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999.
Stengel B; Billon S; Van Dijk PC; Jager KJ; Dekker FW; Simpson K; Briggs JD
Nephrol Dial Transplant; 2003 Sep; 18(9):1824-33. PubMed ID: 12937231
[TBL] [Abstract][Full Text] [Related]
14. Regional and social inequalities in chronic renal replacement therapy in Denmark.
Hommel K; Rasmussen S; Kamper AL; Madsen M
Nephrol Dial Transplant; 2010 Aug; 25(8):2624-32. PubMed ID: 20207710
[TBL] [Abstract][Full Text] [Related]
15. Renal replacement therapy due to type 1 diabetes; time trends during 1995-2010--a Swedish population based register study.
Toppe C; Möllsten A; Schön S; Jönsson A; Dahlquist G
J Diabetes Complications; 2014; 28(2):152-5. PubMed ID: 24332762
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetic patients in Europe.
Raine AE
Diabetologia; 1993 Oct; 36(10):1099-104. PubMed ID: 8243861
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ
Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963
[TBL] [Abstract][Full Text] [Related]
18. Ten-years trends in renal replacement therapy for end-stage renal disease in mainland France: Lessons from the French Renal Epidemiology and Information Network (REIN) registry.
Vigneau C; Kolko A; Stengel B; Jacquelinet C; Landais P; Rieu P; Bayat S; Couchoud C;
Nephrol Ther; 2017 Jun; 13(4):228-235. PubMed ID: 28161264
[TBL] [Abstract][Full Text] [Related]
19. Lifetime risk of renal replacement therapy in Europe: a population-based study using data from the ERA-EDTA Registry.
van den Brand JAJG; Pippias M; Stel VS; Caskey FJ; Collart F; Finne P; Heaf J; Jais JP; Kramar R; Massy ZA; De Meester J; Traynor JP; Reisæter AV; Wetzels JFM; Jager KJ
Nephrol Dial Transplant; 2017 Feb; 32(2):348-355. PubMed ID: 28031344
[TBL] [Abstract][Full Text] [Related]
20. End-stage renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality. EDTA-ERA Registry Committee.
Brunner FP; Selwood NH
Nephrol Dial Transplant; 1994; 9(10):1371-6. PubMed ID: 7816247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
